We are live on
!
Find out more
Travere Therapeutics
TVTX
TVTX
173 hedge funds and large institutions have $736M invested in Travere Therapeutics in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 50 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 175 → 173 (-2)
52% less call options, than puts
Call options by funds: $1.81M | Put options by funds: $3.75M
Holders
173
Holding in Top 10
2
Calls
$1.81M
Puts
$3.75M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$8.6M | |
| 3 | +$7.12M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.15M |
| 5 |
Millennium Management
New York
|
+$5.03M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$9.8M | |
| 3 | -$8.49M | |
| 4 |
Renaissance Technologies
New York
|
-$4.43M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.71M |